Tap the Full Potential

Tap the full potential Politicians need to further strengthen the research base in North Rhine-Westphalia. Opinion By Christoph M. Schmidt Research on the economics of progress suggests that successful technology policy should simultaneously take two complementary routes. First, by shaping the general environment of education, research, and knowledge transfer to be open, competitive, and financially well endowed, sound technology policy lays the

Written byChristoph M. Schmidt
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Research on the economics of progress suggests that successful technology policy should simultaneously take two complementary routes. First, by shaping the general environment of education, research, and knowledge transfer to be open, competitive, and financially well endowed, sound technology policy lays the foundation for the success of individuals and the ascent of new technologies. Using this approach, it is left to the market to determine which ideas are worthwhile to pursue and which are not. Second, by supporting selected technologies directly, technology policy can foster the development of enterprises and industry branches considered to be of major strategic importance for future economic prosperity. In North Rhine-Westphalia (NRW), a particularly important application of this second policy is biotechnology, in particular, industrial and pharmaceutical biotechnology.

BIO.NRW

Unchaining a champion

From Coal to CLIB

Advancing Research

Governmental Vision

It's all about Cells

Andreas Pinkwart

Bayer

Detlev Riesner

Cooling the German Discussion

Dasgip

Homeward ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies